Abstract
Vector-borne diseases are an increasing threat to human health and well-being in the United States. Understanding public perception and practices taken to reduce vector abundance and vector-human contact can guide effective interventions that can mitigate health risks. Nevertheless, vector-borne disease surveys, which are widely used in the field to understand public perception and practices, are often inconsistent in terms of structure and implementation. This protocol is designed to provide guidance for public health professionals and researchers in the development of future KAP studies by ensuring uniformity in design and structure. This manuscript describes a rigorous three-phase protocol for the development of standardized vector-borne disease survey modules that can be used throughout the United States to generate data that are comparable across diverse regions. During phase one, a workshop with subject matter experts and a comprehensive literature review will be conducted to identify survey domains and generate items of interest. Survey items will also be mapped based on two theoretical frameworks, the Health Belief Model and the Risks, Attitudes, Norms, Abilities and Self-Regulation framework, to help gauge individual perceptions of risk severity and self-efficacy. During phase two, a group of expert judges will evaluate survey items based on content relevance, representativeness, and technical quality. During the final phase, cognitive interviews and surveys with target audience groups will be conducted to ensure the face validity of the modules. Participants will be drawn from a diverse range of educational and geographic locations, and computer-assisted personal interviewing will be implemented. The surveys developed through this protocol will be available to researchers aiming to gain deeper insights into the public’s knowledge, attitudes, and practices concerning vector-borne diseases, facilitating the collection of more comparable data across various regions in the United States.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NA
Clinical Protocols
NA
Funding Statement
Yes
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was obtained through the University of Arizona Institutional Review Board in July 2023. STUDY00002911 for components of the protocol. However, full protocol has not yet been submitted and approved as data collection has not yet begun for all aspects of the project.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Not Applicable
Data Availability
NA
NA
